Abstract:BACKGROUND:Survivin is known to be overexpressed in various human malignancies, including pancreatic cancer, and mediates cancer cell proliferation and tumor growth, so the regulation of this molecule could be a new strategy for treating pancreatic cancer. In this study, short hairpin RNAs (shRNAs) specific to survivin were introduced into human pancreatic cancer Patu8988 cells to investigate the inhibitory effects on survivin expression and cell proliferation in vitro and in vivo.METHODS:Three kinds of shRNA specific to the survivin gene were designed and cloned into eukaryotic expression plasmid pGenesil-1 vector. Subsequently the recombinant plasmids were transfected into human pancreatic cancer Patu8988 cells with lipfectamineTM 2000 reagent. The mRNA and protein expressions of survivin in the transiently transfected Patu8988 cells were determined by RT-PCR, flow cytometry, and Western blotting analysis. The proliferation inhibition rates of stably transfected Patu8988 cells were determined by MTT assay. The antitumor activities of the three kinds of survivin-shRNA plasmids were evaluated in BALB/c nude mice inoculated with Patu8988 cells and bearing human pancreatic cancer.RESULTS:The three survivin-shRNA plasmids named pGenesil-1-survivin-1, pGenesil-1-survivin-2 and pGenesil-1-survivin-1+2 (with double interfering RNA sites) were successfully constructed, and were confirmed by restriction enzyme cutting and sequencing. At 48 hours after transfection, the expression of survivin mRNA and protein was inhibited in Patu8988 cells transfected with pGenesil-1-survivin-1, pGenesil-1-survivin-2, and pGenesil-1-survivin-1+2 when compared with that of either pGenesil-1-NC (with scrambled small interfering RNA) transfected cells or control cells (P<0.05). The MTT results showed that the proliferation rates of Patu8988 cells stably transfected with survivin-shRNA plasmids were reduced when compared with that of either pGenesil-1-NC transfected cells or control cells (P<0.01). Furthermore, when Patu8988 cells stably transfected with survivin-shRNA were injected into BALB/c nude mice, tumor growth was dramatically lower and the tumor was smaller than that of either pGenesil-1-NC transfected cells or control cells (P<0.01). The inhibitory effect of pGenesil-1-survivin-1 was the best among the three kinds of survivin-shRNA plasmids, but no combination of inhibitory effects was found in pGenesil-1-survivin-1+2.CONCLUSIONS:shRNAs specific to survivin have gene silencing effects and inhibit pancreatic cancer cell proliferation. shRNA activity against survivin could be of potential value in gene therapy for pancreatic cancer. However, shRNAs with double combining sites did not significantly enhance the interference compared with single site shRNAs, therefore further studies on this are needed.

Knockdown of survivin expression by small interfering RNA suppresses proliferation of two human cancer cell lines.

Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.

[Sirna Targeted Against Survivin Induces Apoptosis of Pancreatic Cancer Cells].

siRNA AGAINST SURVIVIN SUPPRESSES THE PROLIFERATION OF PANCREATIC CANCER CELL PC-2 AND INDUCES ITS APOPTOSIS

[Effects of Sirna Targeted to Survivin in Suppressing Proliferation and Inducing Apoptosis in Breast Cancer MCF-7 Cells].

Survivin Stable Knockdown by Sirna Inhibits Tumor Cell Growth and Angiogenesis in Breast and Cervical Cancers

Silencing of Survivin Expression Leads to Reduced Proliferation and Cell Cycle Arrest in Cancer Cells.

[Silencing of Survivin Gene in Jeko-1 Cell Line with Small Interfering RNA].

siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.

Effect of enhancing the radiosensitivity of pancreatic cancer cell line PC-2 by siRNA against Survivin.

Growth Inhibition Induced by Short Hairpin RNA to Silence Survivin Gene in Human Pancreatic Cancer Cells.

Study of Inhibiting The Expression of Survivin in Pancreatic Cancer Cells with RNA Interference

Antitumor activity of a novel survivin siRNA.

INHIBITING EFFECT OF THE SURVIVIN-TARGETTING siRNA RECOMBINANT EXPRESSION VECTOR ON HUMAN COLON CANCER CELL PROLIFERATION

[Inhibitory Effect of Lentiviral Vectors Expressing Small Interfering RNA Targeting Survivin Gene on Hep-2 Cell Growth in Vitro and in Nude Mice].

Inhibition of survivin expression in BGC-823 cells by RNA interference

Rna Interference-Mediated Inhibition of Endogenous Survivin Expression in Hepatocarcinoma Cell

Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity

Lentivirus-mediated Shrna Targeting XIAP and Survivin Inhibit SW1990 Pancreatic Cancer Cell Proliferation in Vitro and in Vivo.

Lentiviral vector-mediad RNA interference targeted against survivin inhibits survivin expression and induces cell apoptosis of human pancreatic cancer in vitro

The study of inhibitting the expression of survivin in pancreatic cancer cells with RNAi